Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Peripheral Artery Disease V: Postoperative Nursing Management01:23

Peripheral Artery Disease V: Postoperative Nursing Management

During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Retraction notice for "MicroRNA-133b-5p Is Involved in Cardioprotection of Morphine Preconditioning in Rat Cardiomyocytes by Targeting Fas" [Canadian Journal of Cardiology, Volume 32, Issue 8, August 2016, Pages 996-1007. doi:10.1016/j.cjca.2015.10.019].

The Canadian journal of cardiology·2026
Same author

Ciprofol pharmacology and dosing in various populations.

Expert opinion on pharmacotherapy·2025
Same author

Total intravenous anaesthesia in emergency surgery: a narrative review.

Anaesthesia·2025
Same author

Single-Syringe Total Intravenous Anesthesia: Dosing Concerns.

Anesthesia and analgesia·2025
Same author

Remimazolam - drug evaluations: expert opinion on pharmacotherapy.

Expert opinion on pharmacotherapy·2025
Same author

Expanding the role of intranasal dexmedetomidine in peri-operative care.

Anaesthesia·2025
Same journal

Pharmacotherapeutic interventions for pediatric ulcerative colitis.

Expert opinion on pharmacotherapy·2026
Same journal

The rise and fall of TRPV1-targeted analgesia in osteoarthritis: a critical appraisal.

Expert opinion on pharmacotherapy·2026
Same journal

Dopamine transporter and beyond: evolving targets and combination strategies in stimulant use disorder.

Expert opinion on pharmacotherapy·2026
Same journal

GnRH antagonists for the treatment of fibroids and adenomyosis, current evidence and future perspectives.

Expert opinion on pharmacotherapy·2026
Same journal

Pharmacotherapeutic strategies for the management of congenital adrenal hyperplasia.

Expert opinion on pharmacotherapy·2026
Same journal

Current advances in pharmacotherapeutic strategies for the treatment of complicated intra-abdominal infections.

Expert opinion on pharmacotherapy·2026
See all related articles

Related Experiment Video

Updated: May 13, 2026

Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis
06:59

Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis

Published on: August 26, 2025

Perioperative statin therapy.

Wales W N Chan1, Gordon T C Wong, Michael G Irwin

  • 1Queen Mary Hospital, Department of Anaesthesiology, Pokfulam Road, Hong Kong.

Expert Opinion on Pharmacotherapy
|March 26, 2013
PubMed
Summary
This summary is machine-generated.

Perioperative statin use in high-risk patients undergoing non-cardiac surgery reduces cardiovascular events and mortality. This cost-effective therapy shows promise for renal protection, with ongoing research into optimal dosing and long-term effects.

Related Experiment Videos

Last Updated: May 13, 2026

Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis
06:59

Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis

Published on: August 26, 2025

Area of Science:

  • Cardiology
  • Pharmacology
  • Surgical Outcomes

Background:

  • Statins possess pleiotropic effects beyond lipid lowering, including anti-inflammatory and antioxidant properties.
  • These effects may mitigate the adverse impacts of surgical stress on organ systems during the perioperative period.

Purpose of the Study:

  • To review existing evidence on the impact of perioperative statin administration on postoperative morbidity and mortality.
  • To explore potential benefits such as renal protection and safety profiles.

Main Methods:

  • A comprehensive literature review was conducted using PubMed, Medline, and Scopus databases.
  • Search terms included 'statins,' 'perioperative risk reduction,' 'outcomes,' 'morbidity,' and 'mortality,' with further specific searches on thrombosis, kidney injury, cancer, cost, and safety.

Main Results:

  • Evidence supports reduced cardiovascular morbidity and mortality in high-risk patients undergoing non-cardiac surgery with perioperative statin use.
  • This approach is highly cost-effective with a low incidence of reported adverse events.

Conclusions:

  • Perioperative statin therapy is beneficial for reducing cardiovascular complications in high-risk surgical patients.
  • Emerging data suggest renal protective benefits, warranting further investigation through prospective studies.
  • Future research should focus on optimal statin type, timing, dosage, and long-term safety, including withdrawal effects.